Skip to main content
. Author manuscript; available in PMC: 2008 Jul 19.
Published in final edited form as: Clin Trials. 2006;3(5):443–456. doi: 10.1177/1740774506070727

Table 5.

Expected relative bias and efficiency associated with non-consent, which is assumed to occur at a rate of 15% for individuals with Genotype X and 5% among others. Both Genotype X and the outcomes are assumed to have prevalence of 50%. Odds ratios are for associations between the outcome and intervention assignment.

Ratio of Gene-Specific ORs For Full Cohort
OR Between Intervention And Outcome Among Non-consenters
Results From Analysis of Consenters Only
Genotype X
Genotype Not X
Observed Ratio of ORs
Standard Error of Observed Ratios of ORs
Relative Bias (%)
Relative Efficiency* (%)
1.00 1.000 0.126 0.0 89.9
1.00 2.00 1.039 0.131 3.9 89.9
1.00 4.00 1.077 0.136 7.7 89.9
(Assumed to be 2.00 in genotype X and in others) 1.00 0.892 0.112 −10.8 89.9
2.00 2.00 0.927 0.117 −7.3 89.9
4.00 0.960 0.121 −4.0 89.9
1.00 0.801 0.101 −19.9 89.9
4.00 2.00 0.832 0.105 −16.8 89.9


4.00
0.862
0.109
−13.8
89.9
1.00 4.638 0.594 15.9 89.4
4.00 1.00 2.00 4.872 0.625 21.8 89.2
4.00 5.058 0.649 26.5 89.0
(Assumed to be 4.00 in genotype X and 1.0 among others) 1.00 4.160 0.531 4.0 89.9
2.00 2.00 4.328 0.553 8.2 89.7
4.00 4.492 0.575 12.3 89.6
1.00 3.723 0.474 −6.9 90.3
4.00 2.00 3.872 0.494 −3.2 90.1
4.00 4.018 0.513 0.0 90.0
*

Square of the ratio of standard errors for the log-linear contrast defined by the 3-way interaction involving genotype, intervention, and outcome